Is Europe a Laggard in Pharmaceuticals? R&D Joint Ventures, Patent Quality and R&D Productivity
Messinis, George (2005) Is Europe a Laggard in Pharmaceuticals? R&D Joint Ventures, Patent Quality and R&D Productivity. Working Paper. Victoria University, Melbourne, Australia.
Has the USA overtaken Europe as the powerhouse of new medicines? If so, is this attributable to a flight of business expenditure in R&D to the USA? This paper answers these questions using a methodology that focuses on R&D productivity and patent quality as key indicators of innovation, accounts for R&D price inflation, and examines the role of both 'performed' R&D and 'extra-mural' R&D. The study provides three new insights: (a) the USA has outperformed Europe in R&D productivity but this is due to Europe's superior performance in sales and patent quality; (b) government expenditure on R&D and extra-mural R&D stimulate international patent collaboration, and (c) the latter is a crucial determinant of patent quality.
|Item Type:||Monograph (Working Paper)|
|Uncontrolled Keywords:||Europe; pharmaceuticals; joint ventures; patent quality; productivity; pharmaceutical industry|
|Subjects:||RFCD Classification > 320000 Medical and Health Sciences
Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES)
|Depositing User:||Mr Angeera Sidaya|
|Date Deposited:||20 Oct 2005|
|Last Modified:||23 May 2013 16:37|
|ePrint Statistics:||View download statistics for this item|
Repository staff only